Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Jazz Pharmaceuticals plcSHS USD(JAZZ) | 1,100,000 | 1,500,000 | +400,000 | $132.46M | $160.09M | 11.94% | +$27.63M |
| Cytokinetics, Incorporated(CYTK) | 2,150,000 | 2,075,000 | -75,000 | $150.74M | $112.42M | 8.38% | -$38.31M |
| Ascendis Pharma A/SADR(ASND) | 525,000 | 750,000 | +225,000 | $79.36M | $102.28M | 7.63% | +$22.92M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 110,000 | 1,800,000 | +1,690,000 | $5.14M | $73.98M | 5.52% | +$68.84M |
| Globus Medical, Inc.CL A(GMED) | 1,000,000 | 900,000 | -100,000 | $53.64M | $61.64M | 4.60% | +$8.00M |
| Insmed Incorporated(INSM) | 750,000 | 750,000 | 0 | $20.35M | $50.25M | 3.75% | +$29.90M |
| BeOne Medicines AGADR(ONC) | 325,000 | 350,000 | +25,000 | $50.83M | $49.93M | 3.72% | -$892.3K |
| Soleno Therapeutics Inc | 1,250,000 | 1,200,000 | -50,000 | $53.50M | $48.96M | 3.65% | -$4.54M |
| Endeavour Silver Corp.(EXK) | 100,000 | 925,000 | +825,000 | $6.91M | $39.08M | 2.91% | +$32.18M |
| Arcellx Inc COMMON STOCK | 100,000 | 675,000 | +575,000 | $6.96M | $37.25M | 2.78% | +$30.30M |
| Immatics N.V.SHS(IMTX) | 1,200,000 | 2,750,000 | +1,550,000 | $12.61M | $31.95M | 2.38% | +$19.34M |
| Janux Therapeutics, Inc.(JANX) | 0 | 725,000 | +725,000 | $0 | $30.37M | 2.26% | +$30.37M |
| Astria Therapeutics Inc | 1,100,000 | 3,250,000 | +2,150,000 | $15.48M | $29.57M | 2.21% | +$14.09M |
| KalVista Pharmaceuticals Inc | 655,000 | 2,300,000 | +1,645,000 | $7.77M | $27.09M | 2.02% | +$19.33M |
| Savara Inc.(SVRA) | 0 | 6,490,000 | +6,490,000 | $0 | $26.15M | 1.95% | +$26.15M |
| iTeos Therapeutics Inc | 0 | 1,750,000 | +1,750,000 | $0 | $25.97M | 1.94% | +$25.97M |
| Applied Therapeutics Inc | 5,110,000 | 5,430,000 | +320,000 | $34.75M | $25.36M | 1.89% | -$9.39M |
| Axsome Therapeutics, Inc.(AXSM) | 0 | 300,000 | +300,000 | $0 | $24.15M | 1.80% | +$24.15M |
| Structure Therapeutics IncADS | 0 | 560,000 | +560,000 | $0 | $21.99M | 1.64% | +$21.99M |
| Liquidia Corporation(LQDA) | 2,000,000 | 1,830,000 | -170,000 | $29.50M | $21.96M | 1.64% | -$7.54M |
| ALX Oncology Holdings Inc.(ALXO) | 2,610,000 | 3,600,000 | +990,000 | $29.10M | $21.71M | 1.62% | -$7.39M |
| uniQure N.V.SHS(QURE) | 4,725,000 | 4,750,000 | +25,000 | $24.57M | $21.28M | 1.59% | -$3.29M |
| Bristol-Myers Squibb Company(BMY) | 0 | 500,000 | +500,000 | $0 | $20.77M | 1.55% | +$20.77M |
| Xenon Pharmaceuticals Inc.(XENE) | 400,000 | 525,000 | +125,000 | $17.22M | $20.47M | 1.53% | +$3.25M |
| Praxis Precision Medicines, Inc.(PRAX) | 210,000 | 440,000 | +230,000 | $12.81M | $18.20M | 1.36% | +$5.38M |
| Day One Biopharmaceuticals Inc COM | 0 | 1,250,000 | +1,250,000 | $0 | $17.23M | 1.28% | +$17.23M |
| Inari Medical Inc | 800,000 | 350,000 | -450,000 | $38.38M | $16.85M | 1.26% | -$21.53M |
| Dianthus Therapeutics, Inc.(DNTH) | 455,000 | 600,000 | +145,000 | $13.65M | $15.53M | 1.16% | +$1.88M |
| Solid Biosciences Inc | 1,035,000 | 2,665,000 | +1,630,000 | $13.79M | $15.11M | 1.13% | +$1.32M |
| Lexeo Therapeutics, Inc.(LXEO) | 175,000 | 840,000 | +665,000 | $2.74M | $13.47M | 1.00% | +$10.73M |
| Apellis Pharmaceuticals Inc COM | 225,000 | 335,000 | +110,000 | $13.23M | $12.85M | 0.96% | -$374.9K |
| Immunome, Inc.(IMNM) | 0 | 1,000,000 | +1,000,000 | $0 | $12.10M | 0.90% | +$12.10M |
| Denali Therapeutics Inc.(DNLI) | 0 | 500,000 | +500,000 | $0 | $11.61M | 0.87% | +$11.61M |
| Nurix Therapeutics, Inc.(NRIX) | 0 | 500,000 | +500,000 | $0 | $10.44M | 0.78% | +$10.44M |
| Black Diamond Therapeutics Inc | 0 | 2,100,000 | +2,100,000 | $0 | $9.79M | 0.73% | +$9.79M |
| BioNTech SEADS(BNTX) | 0 | 100,000 | +100,000 | $0 | $8.04M | 0.60% | +$8.04M |
| Inspire Medical Systems, Inc.(INSP) | 0 | 60,000 | +60,000 | $0 | $8.03M | 0.60% | +$8.03M |
| Pacira BioSciences, Inc.(PCRX) | 80,000 | 280,000 | +200,000 | $2.34M | $8.01M | 0.60% | +$5.67M |
| Dyne Therapeutics, Inc.(DYN) | 0 | 225,000 | +225,000 | $0 | $7.94M | 0.59% | +$7.94M |
| Fulcrum Therapeutics, Inc.(FULC) | 695,000 | 1,160,000 | +465,000 | $6.56M | $7.19M | 0.54% | +$631.2K |
| Alto Neuroscience, Inc.(ANRO) | 250,000 | 620,000 | +370,000 | $3.84M | $6.63M | 0.49% | +$2.79M |
| Fate Therapeutics, Inc.(FATE) | 800,000 | 2,000,000 | +1,200,000 | $5.87M | $6.56M | 0.49% | +$688.0K |
| Allogene Therapeutics Inc | 1,350,000 | 2,200,000 | +850,000 | $6.03M | $5.13M | 0.38% | -$908.5K |
| Passage Bio, Inc.(PASG) | 4,500,000 | 6,052,000 | +1,552,000 | $6.08M | $4.81M | 0.36% | -$1.27M |
| Voyager Therapeutics, Inc.(VYGR) | 600,000 | 600,000 | 0 | $5.59M | $4.75M | 0.35% | -$840.0K |
| Lakefront Biotherapeutics NVADR(LKFT) | 130,000 | 180,000 | +50,000 | $4.19M | $4.46M | 0.33% | +$274.4K |
| Zymeworks Inc.(ZYME) | 0 | 440,000 | +440,000 | $0 | $3.74M | 0.28% | +$3.74M |
| Relmada Therapeutics, Inc.(RLMD) | 1,200,000 | 1,200,000 | 0 | $5.58M | $3.60M | 0.27% | -$1.98M |
| MacroGenics, Inc.(MGNX) | 725,000 | 800,000 | +75,000 | $10.67M | $3.40M | 0.25% | -$7.27M |
| Monte Rosa Therapeutics, Inc.(GLUE) | 0 | 890,000 | +890,000 | $0 | $3.33M | 0.25% | +$3.33M |
| Ventyx Biosciences Inc | 0 | 1,315,000 | +1,315,000 | $0 | $3.04M | 0.23% | +$3.04M |
| PTC Therapeutics, Inc.(PTCT) | 0 | 90,000 | +90,000 | $0 | $2.75M | 0.21% | +$2.75M |
| Verve Therapeutics Inc | 0 | 500,000 | +500,000 | $0 | $2.44M | 0.18% | +$2.44M |
| Iovance Biotherapeutics, Inc.(IOVA) | 0 | 300,000 | +300,000 | $0 | $2.41M | 0.18% | +$2.41M |
| Prime Medicine, Inc.(PRME) | 360,000 | 450,000 | +90,000 | $2.52M | $2.31M | 0.17% | -$207.0K |
| Chimerix Inc | 1,400,000 | 1,400,000 | 0 | $1.48M | $1.23M | 0.09% | -$257.6K |
| Achilles Therapeutics PLCADS | 1,500,000 | 1,500,000 | 0 | $1.88M | $1.22M | 0.09% | -$652.5K |
| Atara Biotherapeutics Inc | 0 | 112,000 | +112,000 | $0 | $952.0K | 0.07% | +$952.0K |
| Reneo Pharmaceuticals Inc | 295,375 | 545,000 | +249,625 | $490.3K | $823.0K | 0.06% | +$332.6K |
| Newamsterdam Pharma Co NV ORDINARY SHARES | 0 | 25,000 | +25,000 | $0 | $480.3K | 0.04% | +$480.3K |
| Affimed NV | 55,000 | 0 | -55,000 | $291.5K | $0 | — | -$291.5K |
| Agios Pharmaceuticals, Inc.(AGIO) | 325,000 | 0 | -325,000 | $9.50M | $0 | — | -$9.50M |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 350,000 | 0 | -350,000 | $52.31M | $0 | — | -$52.31M |
| Alpine Immune Sciences Inc | 350,000 | 0 | -350,000 | $13.87M | $0 | — | -$13.87M |
| argenx SEADR(ARGX) | 50,000 | 0 | -50,000 | $19.69M | $0 | — | -$19.69M |
| AstraZeneca PLCADR(AZN) | 400,000 | 0 | -400,000 | $27.10M | $0 | — | -$27.10M |
| Atara Biotherapeutics Inc | 2,800,000 | 0 | -2,800,000 | $1.94M | $0 | — | -$1.94M |
| BioMarin Pharmaceutical Inc.(BMRN) | 175,000 | 0 | -175,000 | $15.28M | $0 | — | -$15.28M |
| Bio-Rad Laboratories IncCL A | 15,000 | 0 | -15,000 | $5.19M | $0 | — | -$5.19M |
| Geron Corporation(GERN) | 2,200,000 | 0 | -2,200,000 | $7.26M | $0 | — | -$7.26M |
| Incyte Corporation(INCY) | 200,000 | 0 | -200,000 | $11.39M | $0 | — | -$11.39M |
| Krystal Biotech, Inc.(KRYS) | 45,000 | 0 | -45,000 | $8.01M | $0 | — | -$8.01M |
| Lyell Immunopharma, Inc.(LYEL) | 130,000 | 0 | -130,000 | $289.9K | $0 | — | -$289.9K |
| Lyra Therapeutics Inc | 800,000 | 0 | -800,000 | $4.98M | $0 | — | -$4.98M |
| Neurocrine Biosciences, Inc.(NBIX) | 710,000 | 0 | -710,000 | $97.92M | $0 | — | -$97.92M |
| Novavax, Inc.(NVAX) | 500,000 | 0 | -500,000 | $2.39M | $0 | — | -$2.39M |
| Sarepta Therapeutics, Inc.(SRPT) | 100,000 | 0 | -100,000 | $12.95M | $0 | — | -$12.95M |
| Shockwave Medical Inc | 25,000 | 0 | -25,000 | $8.14M | $0 | — | -$8.14M |
| TG Therapeutics, Inc.(TGTX) | 1,050,000 | 0 | -1,050,000 | $15.97M | $0 | — | -$15.97M |
| Viking Therapeutics, Inc.(VKTX) | 75,000 | 0 | -75,000 | $6.15M | $0 | — | -$6.15M |